NASDAQ:HALO

Halozyme Therapeutics Stock Insider Trading

etoro logo Buy HALO
*Your capital is at risk
$80.84
+3.02 (+3.88%)
At Close: Jul 23, 2026

Halozyme Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -68.58. In total, the insiders bought 721.01K and sold 251.08K HALO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-68.58
Buy 721.01K shares
Sell 251.08K shares
54% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Jul 01, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -68.58.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Apr 01, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 1 000
Value: $65.7K
Apr 01, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 19 000
Value: $1.24M
Mar 23, 2026
Buy
Common Stock
J-Other
Ramsay David A
Officer
Officer 0
Value: $0
Mar 10, 2026
Buy
Common Stock
M-Exempt
Caudill Cortney
SVP, Chief Operating Officer
C-Suite Officer 1 546
Value: $51.8K
Mar 10, 2026
Buy
Option to Purchase Common Stock
M-Exempt
Caudill Cortney
SVP, Chief Operating Officer
C-Suite Officer 1 546
Value: $51.8K
Mar 10, 2026
Sell
Common Stock
S-Sale
Caudill Cortney
SVP, Chief Operating Officer
C-Suite Officer 8 857
Value: $599.1K
Mar 09, 2026
Buy
Option to Purchase Common Stock
M-Exempt
Caudill Cortney
SVP, Chief Operating Officer
C-Suite Officer 20 000
Value: $670.2K
Mar 09, 2026
Buy
Common Stock
M-Exempt
Caudill Cortney
SVP, Chief Operating Officer
C-Suite Officer 20 000
Value: $670.2K
Mar 09, 2026
Sell
Common Stock
S-Sale
Caudill Cortney
SVP, Chief Operating Officer
C-Suite Officer 17 900
Value: $1.21M
Mar 09, 2026
Sell
Common Stock
S-Sale
Caudill Cortney
SVP, Chief Operating Officer
C-Suite Officer 2 100
Value: $143.3K
Mar 04, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 2 671
Value: $189.5K
Mar 04, 2026
Buy
Option to Purchase Common Stock
M-Exempt
Torley Helen
President And CEO
CEO / President 10 000
Value: $120.7K
Mar 04, 2026
Buy
Common Stock
M-Exempt
Torley Helen
President And CEO
CEO / President 10 000
Value: $120.7K
Mar 04, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 7 329
Value: $512.6K
Mar 03, 2026
Buy
Option to Purchase Common Stock
M-Exempt
Torley Helen
President And CEO
CEO / President 20 000
Value: $241.4K
Mar 03, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 13 481
Value: $928.2K
Mar 03, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 6 519
Value: $452.0K
Mar 03, 2026
Buy
Common Stock
M-Exempt
Torley Helen
President And CEO
CEO / President 20 000
Value: $241.4K
Mar 02, 2026
Buy
Option to Purchase Common Stock
M-Exempt
Torley Helen
President And CEO
CEO / President 20 000
Value: $241.4K
Mar 02, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 4 100
Value: $283.7K
Mar 02, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 15 322
Value: $1.07M
Mar 02, 2026
Sell
Common Stock
S-Sale
Torley Helen
President And CEO
CEO / President 578
Value: $40.7K
Feb 23, 2026
Buy
Common Stock
M-Exempt
Snyder Mark Howard
SVP, Chief Legal Officer
Officer 7 011
Value: $495.3K
Feb 20, 2026
Buy
Restricted Stock Units
M-Exempt
Caudill Cortney
SVP, Chief Operating Officer
C-Suite Officer 2 666
Value: $189.2K
Feb 20, 2026
Buy
Common Stock
M-Exempt
Caudill Cortney
SVP, Chief Operating Officer
C-Suite Officer 2 666
Value: $189.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT HALOZYME THERAPEUTICS
Halozyme Therapeutics
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules a...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
1.37% Jul 21
N
NVDU
$126.01
1.17% Jul 21
DHT
$17.31
6.35% Jul 13
JLL
$299.78
6.54% Jun 24
ROP
$331.60
7.09% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE